RxDoctor Payments Data

David Morris, MD

Family Medicine · West Columbia, SCNPI 1952490864

Payments from drug & device makers

$17,232in general payments, 2019–2025

Across 1,137 payments — averaging $15.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Novo Nordisk$2K
  • AbbVie$1K
  • Pfizer$1K
  • Amgen$775
  • Astellas Pharma US Inc$704
  • plus $10K from 54 others

What the payments were for

  • Food & beverage$17,13799%
  • Education$951%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca106$1,981
Novo Nordisk104$1,597
AbbVie(2 entities)129$1,323
Pfizer82$1,198
Amgen(2 entities)59$775
Astellas Pharma US Inc41$704
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC46$701
Bayer33$594
Amarin Pharma, Inc.36$559
Kowa Pharmaceuticals America, Inc.45$557
Lilly USA, LLC43$556
Boehringer Ingelheim36$535
Abbott29$517
Novartis32$467
Exact Sciences23$374
Azurity Pharmaceuticals, Inc.25$368
Johnson & Johnson22$356
Otsuka America Pharmaceutical, Inc.14$321
Merck23$302
Biohaven Pharmaceutical Holding Company Ltd.16$277
GSK19$264
Teva Pharmaceuticals USA, Inc.15$260
Upsher-smith Laboratories LLC17$222
Arbor Pharmaceuticals, Inc.16$214
Esperion Therapeutics, Inc.10$196
Sanofi-aventis U.S. LLC12$186
Lundbeck LLC9$183
Eisai Inc.10$154
Sumitomo Pharma America, Inc.6$151
Xeris Pharmaceuticals, Inc.8$140
Phathom Pharmaceuticals, Inc.9$135
Antares Pharma, Inc.6$105
Takeda Pharmaceuticals U.S.A., Inc.8$104
Axsome Therapeutics, Inc.5$98
Biohaven Pharmaceuticals, Inc.5$92
Inari Medical, Inc.2$73
Dexcom, Inc.3$62
Renalytix AI, Inc.3$58
Acerus Pharmaceuticals Corporation3$43
Promius Pharma LLC2$37
Shire North American Group Inc2$27
Ironwood Pharmaceuticals, Inc2$26
Insulet Corporation1$26
Boston Scientific1$22
Alnylam Pharmaceuticals Inc.1$21
Clarus Therapeutics Inc.2$20
Sunovion Pharmaceuticals Inc.1$19
Genentech USA, Inc.1$19
Paratek Pharmaceuticals, Inc.1$18
Halozyme Inc1$17
Bausch Health US, LLC1$17
Tolmar, Inc.1$16
Harmony Biosciences LLC1$16
Almatica Pharma LLC1$16
Scynexis, Inc.1$16
E.r. Squibb & Sons, L.L.C.1$15
Abiomed1$14
Corcept Therapeutics1$14
Edwards Lifesciences1$14
Endo Pharmaceuticals Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,232 in reported general payments places this provider in the 95th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$132,795
Medicare patients
297
Services billed
3,780

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide33$66,765
EliquisApixaban51$52,913
FarxigaDapagliflozin Propanediol51$46,272
XareltoRivaroxaban41$42,366
TrulicityDulaglutide23$39,227
JanuviaSitagliptin Phosphate28$28,232
MounjaroTirzepatide11$18,131
BriviactBrivaracetam12$16,515
JardianceEmpagliflozin15$13,976
MyrbetriqMirabegron23$11,900
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$10,589
Janumet XrSitagliptin Phos/Metformin Hcl13$6,076
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$5,261
Celecoxib86$4,419
SteglatroErtugliflozin Pidolate12$4,143

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,597$66,76533 claims
Lilly USA, LLCTrulicity, Mounjaro$556$57,35834 claims
PfizerEliquis$1,198$52,91351 claims
AstraZenecaFarxiga$1,981$46,27251 claims
Johnson & JohnsonXarelto$356$42,36641 claims
MerckJanuvia, Janumet Xr, Steglatro$302$38,45153 claims
Boehringer IngelheimJardiance$535$13,97615 claims
Astellas Pharma US IncMyrbetriq$704$11,90023 claims
GSKTrelegy Ellipta$264$10,58911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in West Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →